title: Assessment of various strategies for 18F-FET PET-guided delineation of target volumes in high-grade glioma patients.
abstract: OBJECTIVE
  The purpose of the study is to assess the contribution of (18)F-fluoro-ethyl-tyrosine ((18)F-FET) positron emission tomography (PET) in the delineation of gross tumor volume (GTV) in patients with high-grade gliomas compared with magnetic resonance imaging (MRI) alone.
  
  
  METHODS
  The study population consisted of 18 patients with high-grade gliomas. Seven image segmentation techniques were used to delineate (18)F-FET PET GTVs, and the results were compared to the manual MRI-derived GTV (GTV(MRI)). PET image segmentation techniques included manual delineation of contours (GTV(man)), a 2.5 standardized uptake value (SUV) cutoff (GTV(2.5)), a fixed threshold of 40% and 50% of the maximum signal intensity (GTV(40%) and GTV(50%)), signal-to-background ratio (SBR)-based adaptive thresholding (GTV(SBR)), gradient find (GTV(GF)), and region growing (GTV(RG)). Overlap analysis was also conducted to assess geographic mismatch between the GTVs delineated using the different techniques.
  
  
  RESULTS
  Contours defined using GTV(2.5) failed to provide successful delineation technically in three patients (18% of cases) as SUV(max) < 2.5 and clinically in 14 patients (78% of cases). Overall, the majority of GTVs defined on PET-based techniques were usually smaller than GTV(MRI) (67% of cases). Yet, PET detected frequently tumors that are not visible on MRI and added substantially tumor extension outside the GTV(MRI) in six patients (33% of cases).
  
  
  CONCLUSIONS
  The selection of the most appropriate (18)F-FET PET-based segmentation algorithm is crucial, since it impacts both the volume and shape of the resulting GTV. The 2.5 SUV isocontour and GF segmentation techniques performed poorly and should not be used for GTV delineation. With adequate setting, the SBR-based PET technique may add considerably to conventional MRI-guided GTV delineation.
authors.affiliation: Service of Nuclear Medicine, Geneva University Hospital, CH-1211, Geneva, Switzerland.
authors.forename: Hansjörg
authors.initials: H
authors.lastname: Vees
authors.forename: Srinivasan
authors.initials: S
authors.lastname: Senthamizhchelvan
authors.forename: Raymond
authors.initials: R
authors.lastname: Miralbell
authors.forename: Damien C
authors.initials: DC
authors.lastname: Weber
authors.forename: Osman
authors.initials: O
authors.lastname: Ratib
authors.forename: Habib
authors.initials: H
authors.lastname: Zaidi
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D005910:Glioma / Q000000981:diagnostic imaging* / Q000473:pathology*; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D049268:Positron-Emission Tomography; D012015:Reference Standards; D047368:Tumor Burden; D014443:Tyrosine / Q000031:analogs & derivatives*
chemical_list: C117289:O-(2-fluoroethyl)tyrosine; D014443:Tyrosine